Order Article Reprints

Bakdach D, Elajez R, Bakdach AR, Awaisu A, De Pascale G, Ait Hssain A. Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation. Journal of Clinical Medicine. 2022; 11(23):6898. https://doi.org/10.3390/jcm11236898

Bakdach, Dana, Reem Elajez, Abdul Rahman Bakdach, Ahmed Awaisu, Gennaro De Pascale, and Ali Ait Hssain. 2022. "Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation" Journal of Clinical Medicine 11, no. 23: 6898. https://doi.org/10.3390/jcm11236898

Bakdach, D., Elajez, R., Bakdach, A. R., Awaisu, A., De Pascale, G., & Ait Hssain, A. (2022). Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation. Journal of Clinical Medicine, 11(23), 6898. https://doi.org/10.3390/jcm11236898